Zura Bio (ZURA) Notes Payables (2021 - 2022)
Zura Bio's (ZURA) quarterly Notes Payables came in at $7.8 million in Q4 2022, up 269955.71% year-on-year from N/an in Q4 2021, and up 2485.5% quarter-over-quarter from $299981.0 in Q3 2022.
Zura Bio (ZURA) Notes Payables (2021 - 2022) Analysis & Trends
Zura Bio's Notes Payables history runs 2 years deep, the most recent figure standing at $7.8 million for Q4 2022.
- On a quarterly basis, Notes Payables rose 269955.71% year-over-year to $7.8 million in Q4 2022; TTM through Dec 2022 was $7.8 million, a 269955.71% increase from a year earlier, with the FY2022 full-year figure at $7.8 million, up 269955.71% from the prior year.
- Notes Payables improved to $7.8 million in Q4 2022 per ZURA's latest filing, from $299981.0 in the prior quarter.
- Across five years, Notes Payables topped out at $7.8 million in Q4 2022 and bottomed at $2872.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zura Bio | 593.66 Mn | 593.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 7.76 Mn |
| Sep 30, 2022 | 299,981.00 |
| Jun 30, 2022 | 102,893.00 |
| Dec 31, 2021 | 2,872.00 |